Terlipressin and somatostatin for portal pressure in liver transplant
Treatments studied
Part of Digestive system clinical trials.
This study tests two medicines (terlipressin and somatostatin) to see how they affect pressure in the portal vein during liver transplant. It may help people with high portal pressure who are getting a right lobe living donor liver transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a right lobe living donor liver transplant.
- You have high blood pressure in the portal vein (causing esophageal varices, low platelets, fluid in the belly, or confusion).
- Your liver disease is classified as Child-Turcotte-Pugh class B or C.
- You do not have a blood clot in the portal vein or severe kidney, heart, or other organ conditions.
- You are not already taking terlipressin for hepatorenal syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial explores using smaller liver grafts in a partial transplant to treat portal hypertension, which may help patients avoid full transplant risks. It compares this approach to standard liver transplant.
This trial tests a new covered stent placed directly into the liver to relieve high blood pressure in the portal vein (the main vein to the liver) and reduce complications like bleeding and fluid build-up. It may offer an option for people with cirrhosis who need a TIPS procedure.
This trial compares patients who have a rare liver condition (porto-sinusoidal vascular disease) with those who have cirrhosis, to see how a procedure called TIPS (a shunt placed in the liver to reduce blood pressure) works for complications like bleeding, fluid buildup, or blood clots.
This study tests a new way to guide a procedure called TIPS, which creates a new path for blood flow in the liver to reduce pressure. The method uses magnetic positioning along with ultrasound to help doctors place the tube more accurately, which may lead to fewer complications.
This trial compares a newer, less invasive method (using an endoscope) to measure pressure in the liver's blood vessels with the standard technique. It may help people with liver disease or suspected cirrhosis better understand their condition.
This early-phase study tests a technique to measure blood pressure changes in people with cirrhosis (scarring of the liver). It may help doctors better understand liver circulation problems and guide safer treatment decisions.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.